Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Iterum Therapeutics plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 186.8K | 442.5K | +255.7K (+136.8%) |
| Value | $187.3K | $393.4K | +$206.2K (+110.1%) |
New holders (3)
Institutions that held Iterum Therapeutics plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apollon Wealth Management, LLC | 200,000 | $214.0K | 0.01% |
| Susquehanna International Group, LLP | 13,150 | $14.1K | 0.00% |
| Sabby Management, LLC | 75,000 | – | – |
Sold out (3)
Institutions that held Iterum Therapeutics plc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Krilogy Financial LLC | 20,000 | $20.0K |
| Focused Wealth Management, Inc | 6,666 | $6.67K |
| Northwestern Mutual Wealth Management Co | 133 | $133 |